Medivation Bidders Will Have To Price In Talazoparib; BMO Sees $68-$76 Takeout Price
July 07, 2016 at 15:33 PM EDT
As multiple suitors line up to acquire Medivation Inc (NASDAQ: MDVN), BMO Capital said a winning bid will require an acceptable value ...
